Redwood Bank, a new UK SME Business bank that has recently secured its banking licence has made two senior appointments to its Board as part of its “Mobilisation” prior to launch later in 2017. David Buckley has been appointed Chairman and is a Non-Executive Director, and Nigel Boothroyd will join

UK peer-to-peer finance platform Assetz Capita has appointed Samantha Williamson to its rapidly expanding Regional Relationship Director team. She will cover the South Manchester region, working closely alongside local businesses and guiding them through the borrowing process.  Williamson joined Assetz Capital from Positive Commercial Finance where she was a Business Development

Atlas Venture has appointed Kevin Bitterman as a partner. Bitterman brings a wealth of experience and an accomplished record in startup creation and venture investing. “I couldn’t be more thrilled to join Atlas at such an exciting time for the firm,” said Bitterman. “Atlas has a deep commitment to transforming

Private markets investment firm Adams Street Partners (Adams Street) has established a new Munich office led by veteran industry professional Martin vom Hagen.  Vom Hagen joins the firm as a Partner and will focus on the development of institutional client and consultant relationships within Germany, Austria, and Switzerland as the

Eurazeo has launched Eurazeo Brands, a new division to invest in US and European consumer brands with global growth potential.   Jill Granoff, an executive with over 25 years’ experience building brands in the fashion, beauty and retail industries, joins the firm as CEO of Eurazeo Brands effective immediately.   She will

Business advisory firm FRP Advisory has strengthened its UK operation with the promotions to director of Emily Ball and Yasmin Bikha, both based in the Leicester and Nottingham offices.   Ball and Bikha are experienced restructuring advisers with broad connections across the East Midlands and both are licensed insolvency practitioners and qualified

ViraTherapeutics, a biopharmaceutical company developing virus-based immunotherapeutics, which is backed by Boehringer Ingelheim Venture Fund (BIVF), has appointed Dr Heinz Schwer as CEO.   He takes over the position from interim CEO and co-founder Professor Dr Dorothee von Laer, who will remain a scientific adviser.   Schwer is a biotech

YFM Equity Partners has appointed Andy Thomas as investment director.   Based in the Manchester office, Thomas will be focussed on sourcing and leading new investments as part of the Northern team led by David Gee.   Thomas joins from Maven Capital Partners, where he helped to establish the Greater